BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The Company's pipeline currently includes three product candidates for the treatment of cancer.
7-10 December, 2013, 55th ASH Annual Meeting and Exposition, New Orleans, USA
8-12 December, 2013, 24th Annual Antibody Engineering & Therapeutics, Huntington Beach, USA
23-26 June, 2014, BIO International Convention, San Diego, USA
BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have three antibody therapeutics in development. Find out more »
Latest Share Price
BioInvent is currently running early-stage clinical trials with its products. Click here to find out more »